| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $472.60M | $525.21M | $479.03M | $420.62M | $215.27M |
| R&D | $375.61M | $382.97M | $347.94M | $297.44M | $151.50M |
| SG&A | $97.00M | $142.24M | $131.09M | $123.18M | $63.77M |
| Operating Income | -$472.60M | -$525.21M | -$479.03M | -$420.62M | -$215.27M |
| Interest Expense | – | – | $2.38M | $2.40M | $1.42M |
| Tax Expense | $1.54M | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$435.05M | -$477.86M | -$445.14M | -$411.91M | -$45.97M |
| EPS (basic) | -0.7600 | -0.9400 | -0.9600 | -0.9500 | -0.1100 |
| EPS (diluted) | -0.7600 | -0.9400 | -0.9600 | -0.9500 | -0.5200 |
| Shares (diluted) | $575.95M | $508.10M | $462.24M | $432.97M | $409.51M |